share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $14

Moomoo 24/7 ·  Mar 20 05:31

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $11 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment